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Objective: Disrupting thalamocortical activity patterns has proven to be a promising approach to stop generalized
spike-and-wave discharges (GSWDs) characteristic of absence seizures. Here, we investigated to what extent modula-
tion of neuronal firing in cerebellar nuclei (CN), which are anatomically in an advantageous position to disrupt cortical
oscillations through their innervation of a wide variety of thalamic nuclei, is effective in controlling absence seizures.
Methods: Two unrelated mouse models of generalized absence seizures were used: the natural mutant tottering,
which is characterized by a missense mutation in Cacna1a, and inbred C3H/HeOuJ. While simultaneously recording
single CN neuron activity and electrocorticogram in awake animals, we investigated to what extent pharmacologically
increased or decreased CN neuron activity could modulate GSWD occurrence as well as short-lasting, on-demand
CN stimulation could disrupt epileptic seizures.
Results: We found that a subset of CN neurons show phase-locked oscillatory firing during GSWDs and that manipu-
lating this activity modulates GSWD occurrence. Inhibiting CN neuron action potential firing by local application of
the c-aminobutyric acid type A (GABA-A) agonist muscimol increased GSWD occurrence up to 37-fold, whereas
increasing the frequency and regularity of CN neuron firing with the use of GABA-A antagonist gabazine decimated
its occurrence. A single short-lasting (30–300 milliseconds) optogenetic stimulation of CN neuron activity abruptly
stopped GSWDs, even when applied unilaterally. Using a closed-loop system, GSWDs were detected and stopped
within 500 milliseconds.
Interpretation: CN neurons are potent modulators of pathological oscillations in thalamocortical network activity dur-
ing absence seizures, and their potential therapeutic benefit for controlling other types of generalized epilepsies
should be evaluated.
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Absence epilepsy is among the most prevalent formsof generalized epilepsy among children and is char-
acterized by sudden periods of impaired consciousness
and behavioral arrest.1,2 Like other types of generalized
epilepsies, absence seizures are electrophysiologically
defined by oscillatory activity in cerebral cortex and the
thalamic complex.3 Thalamocortical oscillations are pri-
marily caused by excessive cortical activity and can be
identified in the electrocorticogram (ECoG) as general-
ized spike-and-wave discharges (GSWDs).3,4 The under-
lying excessive cortical activity not only excites thalamic
neurons, but also provides potent bisynaptic inhibition
View this article online at wileyonlinelibrary.com. DOI: 10.1002/ana.24399
Received Nov 7, 2014, and in revised form Mar 2, 2015. Accepted for publication Mar 3, 2015.
Address correspondence to Dr Hoebeek, Department of Neuroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands.
E-mail: f.hoebeek@erasmusmc.nl
From the 1Department of Neuroscience, Erasmus Medical Center, Rotterdam, the Netherlands; 2Science and Technology Research Institute, University
of Hertfordshire, Hatfield, United Kingdom; 3Bioelectronics Section, Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft
University of Technology, Delft, the Netherlands; 4Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands; 5Netherlands
Institute for Neuroscience, Royal Dutch Academy for Arts and Sciences, Amsterdam, the Netherlands; and 6Department of Human Genetics, Leiden
University Medical Center, Leiden, the Netherlands
Additional Supporting Information may be found in the online version of this article.
VC 2015 The Authors Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association. This is an
open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and
distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are
made. 1027
by means of cortical axonal collaterals to the inhibitory
reticular thalamic nucleus.3,5–7 Excess tonic c-aminobutyric
acid (GABA)-mediated inhibition in thalamus may also
contribute to absence seizures.3,7,8 Oscillatory cortical activ-
ity thereby poses a dual excitation–inhibition effect on
thalamic neurons, which drives thalamocortical network
oscillations.5,7–9
Recent studies in several rodent models indicate
that direct stimulation of thalamic nuclei10 or cerebral
cortex11 can be effective in disrupting thalamocortical
oscillations and thereby stopping generalized oscillations
in thalamocortical networks, such as GSWDs. Apart
from direct interventions in thalamus and cortex, tha-
lamic afferents can affect the balance in excitation and
inhibition and thereby potentially mediate thalamocorti-
cal oscillations. One of the initial stimulation sites to
prevent seizures in epileptic patients was the cerebellar
cortex.12–18 Yet, as shown in 3 controlled, blind stud-
ies,19–21 the impact of these cerebellar surface stimula-
tions was highly variable and probably reflects
irregularities in the converging inputs from superficial
and deeper parts of the cerebellar cortex neurons to the
cerebellar nuclei (CN).22
Given the considerable divergence of excitatory axo-
nal projections from the CN to a wide range of motor,
associative, and intralaminar thalamic nuclei,4,6,23–29 we
considered this region an ideal candidate to effectively
modulate thalamocortical oscillations. We hypothesized
that altering the firing patterns of CN neurons should
affect GSWD occurrence. To test this hypothesis, we uti-
lized homozygous tottering (tg) mice that frequently show
absence seizures and harbor a P601L missense mutation in
the Cacna1a gene that encodes the pore-forming a1A-subu-
nit of voltage-gated CaV2.1 Ca
21 channels.30,31 Once we
established that tg CN neurons showed oscillatory action
potential firing patterns comparable to that found in rat
models for absence epilepsy,32 we assessed the effect of
increasing or decreasing CN neuronal firing on GSWD
occurrence by local pharmacological interventions using
modulators of GABAA-mediated neurotransmission. In
addition, we generated a closed-loop detection system for
on-demand optogenetic stimulation to stimulate CN neu-
rons with millisecond precision. Finally, to exclude the
possibility that our design of intervention is tailored to the
specific pathophysiology of tg mice, we extended our key
experiments to an unrelated mouse model for absence epi-
lepsy: the C3H/HeOuJ inbred mouse line.33
Materials and Methods
All experiments were performed in accordance with the Euro-
pean Communities Council Directive. Protocols were reviewed
and approved by local Dutch experimental animal committees.
Animals
Data were collected from 4- to 30-week-old homozygous and
wild-type littermates of natural mutant tg mice and 8- to 10-
week-old inbred C3H/HeOuJ mice. Male and female tg and
wild-type littermates were bred using heterozygous parents.
The colony, which was originally obtained from Jackson Labo-
ratory (Bar Harbor, ME), was maintained in C57BL/6NHsd
purchased from Harlan Laboratories (Horst, the Netherlands).
Conformation of the presence of the tg mutation in the
Cacna1a gene was obtained by polymerase chain reaction using
50-TTCTGGGTACCAGATACAGG-30 (forward) and 50-
AAGTGTCGAAGTTGGTGCGC-30 (reverse) primers (Euro-
gentech, Seraing, Belgium) and subsequent digestion using
restriction enzyme NsbI at the age of postnatal day (P) 9 to
P12. Male inbred C3H/HeOuJ mice were purchased from
Charles River Laboratories (Wilmington, MA).
Experimental Procedures
SURGERY. Mice were anesthetized with isoflurane (4% in
0.5l/min O2 for induction and 1.5% in 0.5l/min O2 for main-
tenance). The skull was exposed, cleaned, and treated with
OptiBond All-In-One (Kerr Corporation, Orange, CA) to
ensure adhesion of a light-curing hybrid composite (Charisma;
Heraeus Kulzer, Hanau, Germany) to the skull to form a pedes-
tal. Subsequently, five 200lm Teflon-coated silver ball tip elec-
trodes (Advent Research Materials, Eynsham, UK) or five 1mm
stainless steel screws were subdurally implanted for cortical
recordings by ECoG. Four of the electrodes were bilaterally
positioned above the primary motor cortex (11mm anterior-
posterior [AP]; 61mm medial - lateral [ML] relative to
bregma) and primary sensory cortex (21mm AP;6 3.5mm
ML). A fifth electrode was placed in the rostral portion of the
interparietal bone to serve as reference (21mm AP relative to
lambda). The electrodes and their connectors were fixed to the
skull and embedded in a pedestal composed of the hybrid com-
posite or dental acrylic (Simplex Rapid; Associated Dental
Products, Kemdent Works, Purton, UK). To enable optogenetic
control of neuronal activity in CN, a subset of tg and C3H/
HeOuJ mice received 2 small (0.5mm in diameter) cranioto-
mies in the interparietal bone (22mm AP relative to lambda;
61.5–2mm ML) to initially accommodate the injection pipette
and later the optical fibers. CN were stereotactically injected
bilaterally with 100 to 120nl of the AAV2-hSyn-
ChR2(H134R)-EYFP vector (kindly provided by Dr K. Dei-
sseroth [Stanford University] through the Vector Core at the
University of North Carolina) at a rate of 20nl/min 3 to 6
weeks prior to recordings. To allow electrophysiological record-
ings from CN neurons, all mice received bilateral craniotomies
(2mm diameter) in the occipital bone without disrupting the
dura mater. Finally, a dental acrylic recording chamber (Simplex
rapid) was constructed. The exposed tissue was covered with
tetracycline-containing ointment (Terra-cortril; Pfizer, New
York, NY) and the recording chamber was sealed with bone
wax (Ethicon, Somerville, NJ). After surgery, the mice recovered
for at least 5 days (or 3 weeks in the case of virally injected
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mice) in their home cage and were allowed two 3-hour ses-
sions on consecutive days during which the mice were left
undisturbed to accommodate to the setup.
ELECTROPHYSIOLOGICAL RECORDINGS. During the
accommodation session, the animals’ motor behavior was visu-
ally inspected for behavioral correlates of the oscillatory cortical
activity during episodes of GSWDs. No consistent patterns of
movement were identified during such epileptic activity, as
described before in tg and other rodent models of absence epi-
lepsy.30,32,34 Recordings were performed in awake, head-fixed
animals, lasted no longer than 4 consecutive hours, and were
performed during various times of day. No consistent pattern
was identified in ECoG frequency spectra with respect to the
day–night cycle.35 While being head-restrained, mice were able
to move all limbs freely. Body temperature was supported using
a homeothermic pad (FHC, Bowdoin, ME). For extracellular
single unit recordings, custom-made, borosilicate glass capilla-
ries (outer diameter5 1.5mm, inner diameter5 0.86mm,
resistance5 8–12MX, taper length58mm, tip diameter-
51lm; Harvard Apparatus, Holliston, MA) filled with 2M
NaCl were positioned stereotactically using an electronic pipette
holder (SM7; Luigs & Neumann, Ratingen, Germany). CN
were localized by stereotactic location as well as the characteris-
tic sound and density of neuronal activity.36 To record from
medial CN (MCN), electrodes were advanced through vermal
lobules 6 to 7 with 0 jaw angle relative to the interaural axis
to a depth of 1.6 to 2.4mm. To record from interposed nuclei
(IN), electrodes were advanced through the paravermal or hem-
ispheric part of lobules 6 to 7 using a yaw angle of 10 rela-
tive to the interaural axis to a depth of 1.8 to 2.7mm. To
record from lateral CN (LCN), electrodes were advanced
through the paravermal or hemispheric part of lobules 6 to 7
using a yaw angle of 25 relative to the interaural axis to a
depth of 2.7 to 4mm. A subset of electrophysiological recording
sites was identifiable following Evans blue injections (see below)
and confirmed the accuracy of our localization technique.
ECoGs were filtered online using a 1 to 100Hz band pass filter
and a 50Hz notch filter. Single unit extracellular recordings and
ECoGs were simultaneously sampled at 20kHz (Digidata
1322A; Molecular Devices, Axon Instruments, Sunnyvale, CA),
amplified, and stored for offline analysis (CyberAmp & Multi-
clamp 700A, Molecular Devices).
PHARMACOLOGICAL MODULATION OF CN NEURONAL
ACTION POTENTIAL FIRING. To bilaterally target the CN
for pharmacological intervention, their location was first deter-
mined as described above, after which we recorded 1 hour of
"baseline" ECoG. Next, a borosilicate glass capillary (Harvard
Apparatus; tip diameter55lm) filled with 1 of the follow-
ing mixtures replaced the recording pipette to allow high spa-
tial accuracy of the injection: to decrease CN neuronal action
potential firing, we applied 0.5% muscimol (GABAA-agonist;
Tocris Bioscience, Bristol, UK) dissolved in 1M NaCl (Sigma-
Aldrich, St Louis, MO); to increase CN neuronal action
potential firing, we applied 100mM gabazine (GABAA- antago-
nist; Tocris) dissolved in 1M NaCl; or 1M NaCl for sham
injections. The experimenter was blinded for the solutions
injected. The solution was bilaterally administered to CN by
pressure injections of 150nl at a rate of 50nl/min, follow-
ing which 1 hour of postinjection ECoG was recorded. As an
additional control, similarly sized injections of saline with
either gabazine or muscimol were administered to lobules 6
and 7 and Crus I and Crus II of the cerebellar cortex. The
drugs were injected superficially (0.7–1mm from the surface)
to avoid spread to the CN. The locations of the injections
were identified with the use of electrophysiological recordings
and stereotactic coordinates, and most (19 of 26) CN injec-
tions were histologically confirmed using the fluorescence of
Evans blue (1% in 1M saline supplied to the injected solu-
tion; Supplementary Fig).37 To verify the effects of muscimol,
gabazine, and vehicle, we recorded extracellular activity in the
injected area during 20 to 50 minutes after the injections.
Immediately after acquiring the postinjection ECoG, an over-
dose of sodiumpentobarbital (0.15ml intraperitoneally) was
administered allowing transcardial perfusion (0.9% NaCl fol-
lowed by 4% paraformaldehyde in 0.1M phosphate buffer
[PB]; pH5 7.4) to preserve the tissue for histological verifica-
tion of the injections.
OPTOGENETIC STIMULATION OF CN NEURONS. Optic
fibers (inner diameter5 200lm, numerical aperture5 0.39;
Thor labs, Newton, NJ, USA) were placed 200lm from the
injection site and connected to 470nm or 590nm light-emitting
diodes (LEDs; Thor labs), or 200lm above the brain, that is,
in the "wrong location." Light intensity at the tip of the
implantable fiber was 5506 50lW/mm2 (measured after each
experiment). Activation of LEDs by a single 30- to 300-
millisecond pulse was triggered manually (open-loop) or by a
closed-loop detection system (as described below). In each
mouse, 4 stimulation protocols were used: (1) bilateral stimula-
tion (470nm), (2) unilateral stimulation (470nm), (3) bilateral
stimulation (590nm), and (4) bilateral stimulation (470nm)
with optical fibers outside of the CN (to exclude potential
effects of visual input on the GSWD occurrence.30,32 After the
last experimental session, animals were sedated and perfused (as
described above) to preserve tissue for histological verification
of channelrhodopsin-2 (ChR2) expression.
IMMUNOFLUORESCENCE. After perfusion, the cerebellum
was removed and postfixed in 4% paraformaldehyde in 0.1M
PB for 1.5 hour, placed in 10% sucrose in 0.1M PB at 4C
overnight, and subsequently embedded in gelatin in 30%
sucrose (in 0.1M PB). Embedded brains were postfixed for 2.5
to 3 hours in 30% sucrose and 10% formaldehyde (in Milli-Q;
Millipore, Billerica, MA) and placed overnight in 30% sucrose
(in 0.1M PB) at 4C. Forty-micrometer-thick transversal slices
were serially collected for immunofluorescent 40,6-diamidino-2-
phenylindole (DAPI) staining. To confirm correct localization
of the injections, fluorescence was assessed with images captured
using a confocal laser scanning microscope (LSM 700; Zeiss,
Lambrecht, Germany) at 555nm (Evans blue), 405nm (DAPI),
and 488 to 527nm (green fluorescent protein/yellow fluorescent
protein range) and optimized for contrast and brightness
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manually (Zen 2009 software, Zeiss). The fluorescent images
were captured using a tile-scan function of the Zen software
with a 310 objective and have been optimized for representa-
tion using Adobe Illustrator (Creative Suite 6; Adobe Systems,
San Jose, CA).
Data Analyses
OFFLINE GSWD DETECTION. To accurately determine start
and end of absence GSWDs and the locations of ECoG spikes
(negative ECoG peaks during episodes of GSWDs), a custom-
written GSWD detection algorithm (LabVIEW, National
Instruments, Austin, TX) was used. In short, we detected those
time points in the ECoG for which the first derivative of the
filtered ECoG traces (3rd order Butterworth 1Hz high pass)
changed polarity. The amplitude differences between each point
and both its neighbors were summed to detect fast, continuous
amplitude changes and potential GSWDs with a manually set
amplitude threshold. Series of GSWDs were marked when: (1)
5 threshold-exceeding data points appeared within 1 second
and (2) each of the intervals between the points was <300
milliseconds. Furthermore, we separated GSWDs by applying
the following 4 rules: (1) a point is the first spike of a GSWD
episode if there are no other spikes in the previous 300 milli-
seconds, (2) a point is the last spike of a GSWD episode if
there are no other spikes in the next 350 milliseconds, (3) the
inter-GSWD episode interval is 1 second, and (4) the mini-
mal GSWD duration is 1 second.
GSWD DEFINITION. An ictal period is defined as starting at
the first ECoG spike of a GSWD and ending at the last ECoG
spike. Unless stated otherwise, spike-and-wave discharges that
lasted >1 second and appeared in both M1 and S1 were con-
sidered GSWDs.
An interictal period is defined as the time in between
GSWDs starting 2 seconds after 1 GSWD and ending 2 sec-
onds before the next GSWD.
DETECTION OF ACTION POTENTIALS IN EXTRACELLULAR
RECORDINGS. Extracellular recordings were included if activ-
ity was well isolated and held stable for >100 seconds. Action
potential detection in extracellular traces was performed using
threshold-based analyses with customized MATLAB (Math-
Works, Natick, MA) routines incorporating principal compo-
nent analysis of the spike waveform or with the MATLAB-
based program SpikeTrain (Neurasmus, Erasmus MC Holding,
Rotterdam, the Netherlands).
GSWD-RELATED FIRING PATTERN MODULATION. A
custom-written algorithm in LabVIEW was used to assess
whether CN neurons showed GSWD-modulated firing patterns
during GSWDs in the ECoG of the contralateral primary sen-
sory cortex (in the case of medial CN neurons) or primary
motor cortex (in the case of interposed or lateral CN neurons).
The minimum duration per episode was set at 2 seconds to
construct GSWD-triggered raster plots and peri-GSWD time
histograms (PSTHs) with a 5-millisecond bin width, which
allowed us to determine: (1) modulation amplitude: the ampli-
tude difference between the peak and trough near t5 0; (2)
modulation frequency: frequency of the sine wave that fits the
PSTH best; and (3) mean power at GSWD frequency: a fast
Fourier transform (fft) between 6 and 9Hz (GSWD frequency
range). Next, the interspike intervals (ISIs) used for this PSTH
were randomly shuffled 500 times and converted into a new
PSTH with 5-millisecond bin width to create normal distribu-
tions of modulation amplitude and mean power at GSWD fre-
quency. Z scores were calculated for the real and shuffled data
by applying: Z5 (X2 m)/r, where X5 the value based on the
original PSTH, m5 the mean of the bootstrapped normal dis-
tribution, and r5 its standard deviation (SD). Cells were iden-
tified as GSWD modulated if: (1) the modulation amplitude
was significantly higher than expected by chance (Z 1.96,
p 0.05), (2) the cell modulated at GSWD frequency (6–
9Hz), and (3) the mean power at GSWD frequency was signifi-
cantly higher than expected by chance (Z 1.96, p 0.05).
Because all CN neurons that showed significant Z scores of
mean power at GSWD frequency also showed significantly
higher modulation amplitudes, the former was used for further
analyses. The term Z score refers to mean power at GSWD fre-
quency unless stated otherwise.
COHERENCE. To determine the spectral coherence between the
activity of a CN neuron and the ECoG signal during GSWDs, a
custom-written MATLAB routine was used. The extracellular signal
was time-binned at 1-millisecond precision, convolved with a
sinc(x)-kernel (cutoff frequency5 50Hz) and downsampled to
290Hz. The ECoG signal was directly downsampled to 290Hz.
The magnitude squared coherence was calculated per GSWD epi-
sode using Welch’s averaged, modified periodogram method and is
defined as: Cxy(f)5|Pxy(f)|
2/Pxx(f)*Pyy(f) with the following parame-
ters: window5 290 (Hamming), noverlap5 75%, length of fft
(nfft)5 290, sampling frequency5 290 (due to the window size,
only GSWDs> 1.5 seconds were considered). The coherence value
per GSWD was defined as the maximum coherence in the 6 to 9Hz
frequency band; a weighted average per cell based on GSWD dura-
tion was used.
FIRING PATTERN PARAMETERS. Firing patterns parameters
were assessed using custom-written LabVIEW-based programs
calculating firing frequency, coefficient of variation (CV) of
ISIs5rISI/mISI, CV25 2|ISIn112 ISIn|/(ISIn111 ISIn), and
burst index5 number of action potentials within bursts/total
number of action potentials in a recording, where a burst is
defined as 3 consecutive action potentials with an ISI 10
milliseconds. CV reports regularity of firing throughout the
whole recording and CV2 quantifies the regularity of firing on
a spike-to-spike basis.38 Firing pattern parameters were specifi-
cally calculated for ictal and interictal periods.
REGRESSION ANALYSES OF INTERICTAL CN ACTIVITY. To
evaluate whether there is a type of CN neuron that is predis-
posed for ictal phase-locking during GSWDs, we analyzed the
neurons’ interictal activity using a custom-made MATLAB
routine, aiming to probe the predictability of the ictal activ-
ity. We used Gaussian process regression,39 which is
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considered to be among the best nonlinear regression meth-
ods, to determine whether the GSWD modulation of the
activity was predictable from the interictal activity of the neu-
rons. The measures that enabled the prediction of the modu-
lation amplitude most accurately were CV, log-interval
entropy, firing frequency, and permutation entropy. The inter-
ictal parts of the extracellular recordings were divided into 1-
second bins. To calculate the log-interval entropy, in which
entropy measures the predictability of a system, first a natural
logarithm of the intervals, in milliseconds, was taken to con-
struct a histogram with a bin width of 0.02 loge (time). Fur-
thermore, a Gaussian convolution was performed using a
kernel of one-sixth SD of the log(ISIs).
The entropy of the ISI histogram p(Ii) was calculated by:
EntðIÞ52
XN
i51
pðIiÞlog2pðIiÞ (1)
Furthermore, we analyzed the permutation entropy,
which is calculated as the predictability of the order of neigh-
boring ISIs rather than the actual values of the ISIs.40
NORMALIZED GSWD OCCURRENCE AND DURA-
TION. GSWDs were detected using the offline ECoG detec-
tion algorithm described above. Total number of GSWDs and
average GSWD duration were calculated and normalized to
baseline values.
ASSESSMENT OF CELLULAR RESPONSES TO OPTOGE-
NETIC STIMULATION. Action potentials were detected as
described above. A custom-written LabVIEW program was used
to construct light-triggered raster plots and peri–stimulus time
histograms with a 5-millisecond bin width. Changes in CN
neuronal firing rate upon optical stimulation were subsequently
determined by calculating the total number of action potentials
during light pulses divided by the total length of the pulse and
compared with the baseline firing rate (calculated from the total
recording time excluding the optogenetic stimulation). In the
current study, we consider differences in action potential firing
rate exceeding 25% as responsive.
ASSESSMENT OF IMPACT OF OPTOGENETIC CEREBELLAR
OUTPUT STIMULATION ON GSWDS. The start and end of
seizures were identified using the offline GSWD detection
method described above. A custom-written LabVIEW program
was used to assess the effectiveness of optogenetic stimulation
in stopping GSWDs. Only light pulses triggered prior to the
natural end of the seizure were used for analysis. The time dif-
ference between the light pulse and the end of the seizure was
calculated. The seizure was considered "stopped by the optoge-
netic stimulation" when this time difference did not exceed 150
milliseconds. Mean power at GSWD frequency (6–9Hz) was
calculated using FFT of the ECoG signal recorded during 1-
second or 0.5-second (in the case of closed-loop optogenetic
stimulation) time periods before and after the light pulse. Aver-
aged responses to light pulses are represented per animal and
per stimulus condition by averaging complex Morlet wavelets of
4-second windows ranging from 2 seconds before to 2 seconds
after the stimulus.
ASSESSMENT OF ONSET OF OPTICAL CEREBELLAR NUCLEI
STIMULATION RELATIVE TO GSWD CYCLE. The time dif-
ference between the onset of stimulation and the last spike
before stimulation was calculated and divided by the median
length of 1 GSWD during that episode, representing 1 cycle of
360. The outcome was subsequently multiplied by 360. Note
that the optogenetic stimuli were not initiated with a fixed
delay after the occurrence of an ECoG spike; the delay
depended on the visual interpretation and reaction speed of the
experimenter (for manual activation of the LED) or on the
closed-loop detection system for which the delay depends on
the variability of the ECoG directly prior to the GSWDs (see
below and van Dongen et al41).
CLOSED-LOOP GSWD DETECTION. The GSWD detection
system has been implemented using a real-time, digital wavelet-
filter setup. The analog pre-filter used for digitization has 4
functions: (1) amplification, (2) offset injection to match the
signal to the input range of the analog to digital converter
(ADC), (3) artifact removal by using a second-order 0.4Hz
high-pass filter, and (4) antialiasing by means of a second-order
23.4Hz low-pass filter. The filter is realized using discrete com-
ponents on a prototype printed circuit board (PCB). Following
the PCB, the wavelet filter functionality is implemented on a
TI Sitara AM335x ARM microprocessor (Texas Instruments,
Dallas, TX). It first digitizes the signal from the analog filter
with its integrated ADC using a sampling frequency of 100Hz.
Subsequently the signal is filtered using a wavelet filter and the
GSWD episode is detected using signal thresholding. Upon
detection an output LED is switched on to stimulate the target
area in the cerebellum. Wavelet filters have previously been suc-
cessfully applied for real-time GSWD detection.42 Here we
applied a complex Morlet wavelet at 6.7Hz that resembled a
GSWD. The wavelet filter was implemented as a finite impulse
response filter by truncating the ideal complex Morlet wavelet
as described earlier.43 Using the 2 thresholds that are set man-
ually during a recording session, the GSWDs are detected dur-
ing a positive, high-threshold crossing and the detection is
ended upon a negative, low-threshold crossing.
STATISTICAL ANALYSES. Statistical differences in firing pat-
tern parameters between independent groups of CN neuronal
recordings (eg, from tg mice, their wild-type littermates,
GSWD-modulated and non–GSWD-modulated, before and
after gabazine injection) were determined using multivariate
analyses of variance (MANOVAs) with firing frequency, CV,
CV2, and burst index as dependent variables and group as
independent variable. When a MANOVA showed a significant
result, post hoc analyses of variance (ANOVAs) were used to
assess contributions of individual firing pattern parameters with
Bonferroni corrected p-values.
Differences in coherence value between GWSD-
modulated and non–GWSD-modulated cells were assessed
using unpaired samples t tests. Cochran and Cox adjustment
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for the standard error of the estimate and the Satterthwaite
adjustment for the degrees of freedom were used because equal-
ity of variances was not assumed.
Differences in normalized number of GSWD episodes
and their duration between traces pre- and postinjection of
either muscimol, gabazine, or saline were tested by using
nonparametric Friedman ANOVAs with 1 within-subjects
factor (ie, time period) with 2 levels (baseline and
postinjection).
Differences in mean power at 6 to 9Hz before and after
a light pulse were tested using values from all individual pulses
by use of repeated measures analysis of covariance (ANCOVA)
with 1 within-subjects factor (ie, period) with 2 levels (before
and after light pulse) and mouse number added as covariate to
correct for variance in the within-subject factor explained by
variance between mice. To test whether the time difference
between the last ECoG spike before optogenetic stimulation
and the subsequent spike deviates from the median interval
between 2 ECoG spikes in "stopped seizures," a similar statisti-
cal approach was used. A repeated measures ANCOVA was
used with 1 within-subject factor with 2 levels, both and ECoG
spike intervals. Mouse number was again added as covariate.
Because the number of seizures not terminated by the optoge-
netic stimulation was low, a nonparametric Friedman ANOVA
was used to test the same difference.
To determine whether the phase angle of the optogenetic
stimulation onset was related to the success rate of stopping
GSWDs, we compared the phase angle distribution of success-
ful attempts to that of the unsuccessful attempts. We tested for
significant differences between these distributions using the
nonparametric 2-sample Kuiper test.
A p-value 0.05 (a) was considered significant unless
Bonferroni correction was used; in that case, a p-value of
a/n was considered significant. Two-tailed testing was used
for all statistical analyses and all were performed using
SPSS 20.0 software (IBM, Armonk, NY). Exact information
and outcomes regarding statistical testing are depicted in
Tables 1 to 7.
Results
GSWD-Related CN Neuronal Activity
We first investigated whether CN neuronal activity and
ECoG were correlated during spontaneous episodes of
GSWDs in awake head-fixed homozygous tg mice (Fig
1). We found no significant differences in GSWD occur-
rence (t24520.002, p5 0.998) and GSWD duration
(t245 0.195, p5 0.847) between male and female tg
mice, which is in line with data from other experimental
animal models of absence epilepsy (reviewed by van Luij-
telaar et al44). Therefore, we grouped data of both gen-
ders. GSWDs appeared simultaneously in bilateral
primary motor (M1) and sensory cortices (S1) at
7.66 0.6Hz with an average duration of 3.66 1.4 sec-
onds (n5 17 mice). The GSWD frequency and appear-
ance were comparable to earlier reports of awake tg and
other rodent models of absence epilepsy.30,32,34,45 During
these GSWDs, action potential firing of a subset of CN
neurons was phase-locked to GSWDs. A typical GSWD-
modulated CN neuron showed oscillatory action poten-
tial firing at GSWD frequency; repetitive firing was
observed during the wave in the ECoG, whereas the
spike was accompanied by a pause in CN neuronal activ-
ity. These GSWD-modulated CN neurons showed signif-
icantly increased coherence with ECoG during seizures
(p 0.001; see Table 1). In each CN type (MCN, IN,
and LCN), a substantial portion of the recorded CN
neurons showed GSWD-modulated firing, with the high-
est percentage (73%; 49 of 67 neurons) in the IN and
35% (35 of 100 neurons) and 44% (19 of 43 neurons)
in the MCN and LCN, respectively. We found no statis-
tical difference (p5 0.512) in the phase of modulation
of neuronal firing relative to the GSWD cycle for these 3
nuclei.
To assess whether GSWD-modulated CN neurons
differed from non-modulating CN neurons in baseline
activity, we compared their interictal firing patterns. Dur-
ing interictal periods GSWD-modulated CN neurons
showed a higher firing frequency and a more irregular,
burstlike firing pattern compared with non-modulated
neurons (p-values< 0.01), and both modulated and non-
modulated groups showed a more irregular firing pattern
and increased burst index compared to CN neurons
recorded from wild-type littermates (p-values< 0.01; see
Fig 1G, Table 1). Gaussian process regression39 revealed
that in tg mice interictal CN neuronal firing was corre-
lated with the ictal firing pattern; 94% of neurons that
phase-locked their activity to GSWDs could be predicted
correctly, based on their interictal firing pattern (see Fig
1H). These data indicate that a large subset of neurons
within each CN consistently shows seizure-modulated
activity, that is, that these GSWD-modulated CN neu-
rons are different from non-modulated neurons in basic,
interictal firing patterns and that GSWD-related modula-
tion can be predicted based on these interictal firing
patterns.
Impact on GSWD Occurrence of
Pharmacological Interventions That Modulate
CN Action Potential Firing
CN neurons provide excitatory input to thalamic neu-
rons4,6,23–29 and thereby potentially contribute to the
excitation–inhibition balance that sets thalamic activity
patterns. Excess tonic inhibition of thalamic activity has
been linked to the occurrence of absence seizures,3,7,8
and therefore we hypothesized that a decrease in CN
output in tg should increase the occurrence of GSWDs,
ANNALS of Neurology
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TABLE 1. CN Action Potential Firing
Tested Data Compared Groups N p t or F-value Statistical Test
Differences in phase relation between CN modulation and GSWD cycle
Phase relation MCN 100 0.512 F(2,100)5 0.674 Watson–Williams
multiple sample test
IN 67
LCN 43
Differences in CN neuronal action potential firing
Coherence tg GSWD-modulated 103 <0.001a t(195.9)5 13.35 Independent
samples t test
tg non-modulated 107
Overall Wild type 94 <0.001a F(4,192)5 68.72 MANOVA
(Pillai’s trace)
tg GSWD-modulated
interictal
103
Firing frequency Wild type 94 0.095 F(1,195)5 2.81 ANOVA (Bonferroni)
tg GSWD-modulated
interictal
103
Coefficient of variation Wild type 94 <0.001a F(1,195)5 58.88 ANOVA (Bonferroni)
tg GSWD-modulated
interictal
103
CV2 Wild type 94 <0.001a F(1,195)5 34.63 ANOVA (Bonferroni)
tg GSWD-modulated
interictal
103
Burst index Wild type 94 <0.001a F(1,195)5 230.86 ANOVA (Bonferroni)
tg GSWD-modulated
interictal
103
Overall Wild type 94 <0.001a F(4,196)5 16.66 MANOVA
(Pillai’s trace)
tg non-modulated
interictal
107
Firing frequency Wild type 94 0.092 F(1,199)5 2.86 ANOVA
(Bonferroni)
tg non-modulated
interictal
107
Coefficient of variation Wild type 94 <0.001a F(1,199)5 15.13 ANOVA (Bonferroni)
tg non-modulated
interictal
107
CV2 Wild type 94 <0.01a F(1,199)5 6.79 ANOVA (Bonferroni)
tg non-modulated
interictal
107
Burst index Wild type 94 <0.001a F(1,199)5 37.99 ANOVA (Bonferroni)
tg non-modulated
interictal
107
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whereas increased CN output should have the opposite
effect. To test this, we locally applied (see Fig 2, Supple-
mentary Fig) either GABAA-agonist muscimol, which
stopped CN neuronal action potential firing (no statisti-
cal comparison was possible due to complete cessation of
action potential firing), or GABAA-antagonist gabazine
(SR-95531), which consistently increased the frequency
(p< 0.01) and regularity of CN neuronal firing
(p< 0.001; see Table 2). Upon bilateral CN injections
with muscimol, the occurrence of GSWDs increased by
160 to 3,700% postinjection (p< 0.01; recorded for 60
minutes; peak of seizure occurrence 34.56 16.5 minutes
after injection; n5 10). In contrast, bilateral CN injec-
tions with gabazine significantly reduced the occurrence
of GSWDs (p< 0.05; first seizure occurred 32.56 17.4
minutes after injection; n5 10) and bilateral sham injec-
tions did not change GSWD occurrence (p5 0.18). The
duration of GSWDs was not significantly changed fol-
lowing muscimol, gabazine, or saline injections in the
CN (muscimol: p5 0.21; gabazine: p5 0.32; saline:
p5 0.41). As a control, we also injected similar quanti-
ties of gabazine or muscimol into the cerebellar cortex;
this had no significant effect on the GSWD occurrence
(p 5 0.66 and 0.32, respectively) or duration (p5 0.66
for both gabazine and muscimol injections). Thus, phar-
macological manipulation of neuronal activity in the
CN, but not the cerebellar cortex, is highly effective in
modulating the occurrence of GSWDs in tg mice. Nota-
bly, we observed that muscimol and gabazine were most
effective when the injections were in the IN and/or LCN
(no statistical difference in impact on GSWD-occurrence
after IN and/or LCN injections; p5 0.70; Mann–Whit-
ney U test) compared to injections in the MCN (p5 0.07
for muscimol and p< 0.05 for gabazine; see Supplemen-
tary Fig, Table 3). To study whether these differences in
impact of pharmacological interventions aimed at the
MCN or the IN and LCN were due to a variable effect on
neuronal activity, we also performed single unit recordings
in the injected CN. Regardless of the injected nucleus,
muscimol effectively silenced all action potential firing
and gabazine consistently increased the firing frequency
and the regularity of action potential firing (all p-val-
ues< 0.01 for firing frequency, CV, and CV2; see Table
4). These findings indicate that although effects of musci-
mol and gabazine on the neuronal activity were similar
throughout all CN, the effect of manipulating activity in
the IN and LCN seems to exert a larger impact on
GSWD-occurrence in the mutants than targeting the
TABLE 1: Continued
Tested Data Compared Groups N p t or F-value Statistical Test
Overall tg GSWD-modulated
interictal
103 <0.001a F(4,205)5 17.84 MANOVA (Pillai trace)
tg non-modulated interictal 107
Firing frequency tg GSWD-modulated
interictal
103 <0.001a F(1,208)5 16.31 ANOVA (Bonferroni)
tg non-modulated interictal 107
Coefficient of variation tg GSWD-modulated
interictal
103 <0.01a F(1,208)5 7.12 ANOVA (Bonferroni)
tg non-modulated interictal 107
CV2 tg GSWD-modulated
interictal
103 <0.01a F(1,208)5 9.47 ANOVA (Bonferroni)
tg non-modulated interictal 107
Burst index tg GSWD-modulated
interictal
103 <0.001a F(1,208)5 62.6 ANOVA (Bonferroni)
tg non-modulated interictal 107
Corresponds to Figure 1.
aStatistically significant.
ANOVA5 analysis of variance; CN5 cerebellar nuclei; GSWD5 generalized spike-and-wave discharge; IN5 interposed nuclei;
LCN5 lateral cerebellar nuclei; MANOVA5multivariate analysis of variance; MCN5medial cerebellar nuclei.
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MCN. Instead, pharmacological interventions in the CN
of wild-type littermates (n5 2) did not evoke GSWD-epi-
sodes (data not shown).
Although it has been shown that pharmacological
interventions can have sex-specific differences in animal
models of epilepsy46 that may contribute to the variability
of the current results, our ECoG recordings did not
show a trend toward a sex-specific impact of CN-specific
muscimol or gabazine application (see Fig 2F–H). This
finding was corroborated by the finding that muscimol
was equally effective in stopping CN action potential
FIGURE 1
FIGURE 1: Cerebellar nuclei (CN) neuronal action potential
firing patterns are modulated during generalized spike-and-
wave discharges (GSWDs). (A) Schematic of recording sites
for electrocorticogram (ECoG) from primary motor (M1) and
sensory (S1) cortices and extracellular single unit CN neuro-
nal (CNN) recordings (Th5 thalamus, hpc5hippocampus).
(B) ECoG from M1 and S1 with GSWD episodes (horizontal
lines), indicating absence seizures. (C) Zoom of M1 episode
outlined in B and simultaneously recorded action potential
firing of a single CN neuron. (D; top panel) Zoom of out-
lined M1 and CNN recording in C. Red lines align ECoG
spike with pause in CNN action potential firing. Bottom
panel: Compass plot of phase difference between ECoG
spike and modulated CNN action potential firing.
IN5 interposed nuclei; LCN5 lateral CN; MCN5medial CN.
(E) Raster plot and accompanying peri–spike-and-wave dis-
charge time histogram of CNN action potentials (AP) for 3
consecutive seizures (t50 is aligned with each ECoG spike).
(F) Distribution of absolute Z scores of mean power at
GSWD frequency as determined by fast Fourier transform
for MCN, IN, and LCN. Note that none of the negative Z
scores was below 21.96, and therefore showing absolute Z
scores does not change the number of data points below
and above the 1.96 cutoff score (corresponding to p<0.05;
horizontal dashed line). Total number of recorded neurons:
MCN, n5100; IN, n567; LCN, n543. (G) Bar plots repre-
senting firing frequency, coefficient of variation, coefficient
of variation 2 (CV2), and burst index for CN neurons
recorded in wild-type littermate (n594; black) and seizure-
modulated (n5103; light gray) and non-modulated CN neu-
rons recorded in tg (n5107; dark gray). For clarity, we trun-
cated the negative error bars. **p<0.01, ***p<0.001
(multivariate analysis of variance, post hoc analyses of var-
iance with Bonferroni correction; see Table 1). (H) Result of
the Gaussian process regression to predict the Z score from
interictal activity parameters (CV, firing frequency, log-
interval entropy, and permutation entropy) represented as a
confusion matrix. The prediction is characterized as being a
true positive (tp) when the predicted Z score is >1.96 (dot-
ted line) and the actual Z score is >1.96. A true negative
(tn) is scored when both predicted and actual Z scores are
<1.96. False positive (fp) and false negative (fn) refer to
neurons that have been incorrectly predicted as GSWD
modulated and GSWD non-modulated, respectively. Note
that we were able to achieve a precision of 0.70 and a recall
of 0.94, which means that 70% of CN neurons (n5210) that
were predicted as GSWD modulated actually were GSWD
modulated, and 94% of all GSWD-modulated neurons have
been identified correctly by the model. The Pearson correla-
tion coefficient (r) between the predicted Z score and the
actual Z score was 0.56 with p £ 0.05.
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firing in both male and female mice. Together, these
effects indicate that in the tg animal model of absence
epilepsy CN output forms an integral component of the
neuronal networks involved in generalized epilepsy and
may operate as a potent modulator of GSWD occur-
rence, irrespective of the gender.
Optogenetic Stimulation of Cerebellar Nuclei
The promising impact of long-lasting pharmacological
interventions at the level of the cerebellar output
prompted us to explore whether short-lasting neuromodu-
lation would be equally effective in stopping GSWDs,
that is, whether disrupting oscillatory CN neuronal activ-
ity immediately stops GSWDs. To test this hypothesis,
we virally expressed light-sensitive ChR2 cation channels
in CN neurons (see Fig 3). The optically evoked altera-
tion of CN neuronal firing (see below; Fig 5A) had a
robust effect on GSWD occurrence, in that most if not
all episodes abruptly stopped within 150 milliseconds of
the onset of bilateral stimulation (n5 4; presented per
mouse: 76% [male], 84% [female], 92% [female], and
100% [female] stopped) and in that the power at GSWD
frequency was significantly reduced (p< 0.001; see Fig 3,
Table 5). Moreover, unilateral optical stimulation of CN
FIGURE 2
FIGURE 2: Bimodal modulation of generalized spike-and-
wave discharge (GSWD) occurrence by pharmacological
manipulation of cerebellar nuclei (CN) neuronal (CNN) action
potential firing. (A) Confocal image of coronal cerebellar
slice with bilateral muscimol injections (blue540,6-diami-
dino-2-phenylindole (DAPI); red5Evans blue indicating the
injection sites; IN5 interposed nucleus; IV54th ventricle;
LCN5 lateral CN; MCN5medial CN). (B) Examples of CNN
recordings before and after bilateral muscimol (top) and
gabazine (bottom) injections. (C) Bar plots for the impact of
gabazine on CNN firing as quantified by the difference
between pre- and postgabazine injections (n581 and
n555, respectively) in firing frequency, coefficient of varia-
tion, median CV2, and burst index; **p<0.01, ***p<0.001
(multivariate analysis of variance, post hoc analyses of var-
iance [ANOVAs] with Bonferroni corrections; see Table 2).
(D; top) Representative electrocorticogram (ECoG) of pri-
mary motor cortex (M1) ECoG before and after muscimol
injection; (bottom) representative M1 ECoG before and
after gabazine injection. (E) Time course of the effects of
muscimol (left) and gabazine (right) on the average number
of GSWD episodes (bin size55 minutes). (F, G) Normalized
number of seizures (F) and normalized seizure duration (G)
before and after muscimol (left) and gabazine (right) injec-
tions (1 hour each) for bilateral injections in all CN (n510
for both gabazine and muscimol), in IN/LCN (n56 for mus-
cimol and 5 for gabazine), and in MCN (n54 for muscimol
and 5 for gabazine). Note that for quantification of the sei-
zure duration after gabazine injection, only 9 mice are
included in all CN and 4 mice in the IN/LCN group, because
1 mouse did not show any GSWDs postinjection. Blue dots
indicate data recorded from male mice and red dots from
female. *p<0.05, **p<0.01 (Friedman ANOVAs and Mann–
Whitney U tests; see Tables 2 and 3). (H) Normalized num-
ber of GSWD episodes (left) and normalized GSWD episode
duration (right) for control experiments; saline injections in
the CN and muscimol and gabazine injections in superficial
cerebellar cortical areas.
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neurons proved equally effective in stopping GSWDs in
all recorded cortices, regardless of the laterality (n5 3
females; presented per mouse: 89%, 92%, and 100%
stopped; power reduction: p< 0.001). Bilateral cerebellar
stimulation was ineffective when a different wavelength
(590nm) was applied (n5 3 females; presented per
TABLE 2. Impact of Pharmacological Manipulations on CN Firing and GSWD Occurrence
Tested Data Compared Groups N p F Statistical Test
Effects of bilateral CN gabazine injections on CNN activity
Overall tg pregabazine 81 <0.001a F(4,131)5 39.83 MANOVA (Pillai’s trace)
tg postgabazine 55
Firing frequency tg pregabazine 81 <0.001a F(1,134)5 37.15 ANOVA (Bonferroni)
tg postgabazine 55
Coefficient of variation tg pregabazine 81 <0.001a F(1,134)5 61.21 ANOVA (Bonferroni)
tg postgabazine 55
CV2 tg pregabazine 81 <0.001a F(1,134)5 117.63 ANOVA (Bonferroni)
tg postgabazine 55
Burst index tg pregabazine 81 <0.01a F(1,134)5 8.71 ANOVA (Bonferroni)
tg postgabazine 55
Effects of pharmacological manipulations of CN neurons on GSWDs
GSWD occurrence tg presaline CN 6 0.180 Friedman’s ANOVA
tg postsaline CN
tg premuscimol CN 10 <0.01a Friedman’s ANOVA
tg postmuscimol CN
tg pregabazine CN 10 <0.01a Friedman’s ANOVA
tg postgabazine CN
tg premuscimol cortex 5 0.655 Friedman’s ANOVA
tg postmuscimol cortex
tg pregabazine cortex 5 0.317 Friedman’s ANOVA
tg postgabazine cortex
GSWD duration tg presaline CN 6 0.414 Friedman’s ANOVA
tg postsaline CN
tg premuscimol CN 10 0.206 Friedman’s ANOVA
tg postmuscimol CN
tg pregabazine CN 10 0.317 Friedman’s ANOVA
tg postgabazine CN
tg premuscimol cortex 5 0.655 Friedman’s ANOVA
tg postmuscimol cortex
tg pregabazine cortex 5 0.655 Friedman’s ANOVA
tg postgabazine cortex
Corresponds to Figure 2C, F–H.
aStatistically significant.
ANOVA5 analysis of variance; CN5 cerebellar nuclei; CNN5CN neuronal; GSWD5 generalized spike-and-wave discharge;
MANOVA5multivariate analysis of variance.
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mouse: 0%, 0%, and 5% stopped; power reduction:
p5 0.37) or when the optical fiber was placed outside
the CN region (n5 3 females; presented per mouse: 0%,
5%, and 8% stopped; power reduction: p5 0.28).
The type of seizure detection and on-demand
stimulation described above renders the procedure con-
ceptually unsuitable for clinical implementation in that
it would require constant online evaluation and decision
making by medics.47 Therefore, we developed a brain–
machine interface (BMI) approach by engineering a
closed-loop system for online detection of GSWDs and
subsequent optogenetic stimulation.41 Using offline
analysis, we optimized the performance of a wavelet-
based GSWD detection filter up to an accuracy of
96.5% and a median latency of 424 milliseconds.
When applied online, this on-demand, closed-loop
stimulation proved efficient in detecting and stopping
GSWDs; bilateral optical stimulation of ChR2-
expressing CN neurons stopped 93.4% of GSWDs and
unilateral stimulation stopped 91.8% of GSWDs, which
is also represented by the GSWD frequency power
reduction (n5 3 female; p< 0.001; see Fig 3E, F, Table
5). Together, these data highlight that in a clinically
applicable BMI setting single pulse stimulation of CN
TABLE 3. Impact of Local Pharmacological Manipulations on GSWD Occurrence
Tested Data Compared Groups N p Statistical Test
GSWD occurrence pre vs post tg premuscimol IN/LCN 6 <0.05a Friedman’s ANOVA
tg postmuscimol IN/LCN
tg premuscimol MCN 4 <0.05a Friedman’s ANOVA
tg postmuscimol MCN
tg pregabazine IN/LCN 5 <0.05a Friedman’s ANOVA
tg postgabazine IN/LCN
tg pregabazine MCN 5 <0.05a Friedman’s ANOVA
tg postgabazine MCN
GSWD occurrence medial vs lateral CN tg postmuscimol IN/LCN 6 0.067 Mann–Whitney U test
tg postmuscimol MCN 4
tg postgabazine IN/LCN 5 <0.01a Mann–Whitney U test
tg postgabazine MCN 5
GSWD duration pre vs post tg premuscimol IN/LCN 6 0.102 Friedman’s ANOVA
tg postmuscimol IN/LCN
tg premuscimol MCN 4 1.00 Friedman’s ANOVA
tg postmuscimol MCN
tg pregabazine IN/LCN 5 1.00 Friedman’s ANOVA
tg postgabazine IN/LCN
tg pregabazine MCN 5 0.180 Friedman’s ANOVA
tg postgabazine MCN
GSWD duration medial vs lateral CN tg postmuscimol IN/LCN 6 0.352 Mann–Whitney U test
tg postmuscimol MCN 4
tg postgabazine IN/LCN 5 0.413 Mann–Whitney U test
tg postgabazine MCN 5
Corresponds to Figure 2F–G.
aStatistically significant.
ANOVA5 analysis of variance; CN5 cerebellar nuclei; GSWD5 generalized spike-and-wave discharge; IN5 interposed nuclei;
LCN5 lateral cerebellar nuclei; MCN5medial cerebellar nuclei.
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TABLE 4. Impact of Local Pharmacological Manipulations on CN Spiking Activity
Tested Data Compared Groups N p F-value Statistical Test
Overall tg pregabazine IN/LCN 40 <0.001a F(4,62)5 12.41 MANOVA (Pillai’s trace)
tg postgabazine IN/LCN 27
Firing frequency tg pregabazine IN/LCN 40 <0.01a F(1,65)5 8.80 ANOVA (Bonferroni)
tg postgabazine IN/LCN 27
Coefficient of variation tg pregabazine IN/LCN 40 <0.001a F(1,65)5 23.18 ANOVA (Bonferroni)
tg postgabazine IN/LCN 27
CV2 tg pregabazine IN/LCN 40 <0.001a F(1,65)5 25.13 ANOVA (Bonferroni)
tg postgabazine IN/LCN 27
Burst index tg pregabazine IN/LCN 40 <0.01a F(1,65)5 10.22 ANOVA (Bonferroni)
tg postgabazine IN/LCN 27
Overall tg pregabazine MCN 41 <0.001a F(4,64)5 40.55 MANOVA (Pillai’s trace)
tg postgabazine MCN 28
Firing frequency tg pregabazine MCN 41 <0.001a F(1,67)5 37.53 ANOVA (Bonferroni)
tg postgabazine MCN 28
Coefficient of variation tg pregabazine MCN 41 <0.001a F(1,67)5 60.04 ANOVA (Bonferroni)
tg postgabazine MCN 28
CV2 tg pregabazine MCN 41 <0.001a F(1,67)5 153.36 ANOVA (Bonferroni)
tg postgabazine MCN 28
Burst index tg pregabazine MCN 41 0.614 F(1,67)5 0.61 ANOVA (Bonferroni)
tg postgabazine MCN 28
Overall tg pregabazine IN/LCN 40 <0.001a F(4,76)5 6.28 MANOVA (Pillai’s trace)
tg pregabazine MCN 41
Firing frequency tg pregabazine IN/LCN 40 0.438 F(4,79)5 0.61 ANOVA (Bonferroni)
tg pregabazine MCN 41
Coefficient of variation tg pregabazine IN/LCN 40 0.037 F(4,79)5 4.51 ANOVA (Bonferroni)
tg pregabazine MCN 41
CV2 tg pregabazine IN/LCN 40 0.494 F(4,79)5 0.47 ANOVA (Bonferroni)
tg pregabazine MCN 41
Burst index tg pregabazine IN/LCN 40 <0.001a F(4,79)5 13.53 ANOVA (Bonferroni)
tg pregabazine MCN 41
Overall tg postgabazine IN/LCN 27 <0.001a F(4,50)5 4.29 MANOVA (Pillai’s trace)
tg postgabazine MCN 28
Firing frequency tg postgabazine IN/LCN 27 0.344 F(4,53)5 0.91 ANOVA (Bonferroni)
tg postgabazine MCN 28
Coefficient of variation tg postgabazine IN/LCN 27 0.001a F(4,53)5 13.55 ANOVA (Bonferroni)
tg postgabazine MCN 28
CV2 tg postgabazine IN/LCN 27 <0.01a F(4,53)5 10.16 ANOVA (Bonferroni)
tg postgabazine MCN 28
Burst index tg postgabazine IN/LCN 27 0.801 F(4,53)5 0.64 ANOVA (Bonferroni)
tg postgabazine MCN 28
aStatistically significant.
ANOVA5 analysis of variance; IN5 interposed nuclei; LCN5 lateral cerebellar nuclei; MANOVA5multivariate analysis of var-
iance; MCN5medial cerebellar nuclei.
neurons suffices to stop GSWDs and that unilateral
stimulation is sufficiently powerful to disrupt bilateral
thalamocortical oscillations.
Key Findings Are Replicated in an Unrelated
Mouse Model of Absence Epilepsy
To exclude the possibility that our current findings in tg
are unique to their pathophysiology,30,48,49 we repeated
key experiments in C3H/HeOuJ, an inbred strain with an
absence epilepsy phenotype33 that is unrelated to tg.
Extracellular recordings in awake ECoG-monitored C3H/
HeOuJ mice confirmed that a smaller but substantial
portion (35%) of CN neurons showed phase-locked
action potential firing and significant coherence with
ECoG (p< 0.001) during GSWDs and that this oscilla-
tory firing was more irregular than their interictal firing
pattern (p< 0.001; Fig 4, Table 6). Similar to tg mutants
(see Fig 2), C3H/HeOuJ mice showed significantly more
seizures following local muscimol injections into CN
(p< 0.05; see Fig 4, Table 6). Moreover, also in C3H/
HeOuJ mice optogenetic stimulation reliably stopped
GSWD episodes (n5 3; presented per mouse: 82%,
87%, and 91% stopped) and both bilateral and unilateral
stimuli significantly reduced power at GSWD frequency
(p< 0.01 and p< 0.001, respectively); the closed-loop
detection and intervention system reduced the GSWD
frequency power (p< 0.001 for bilateral and p< 0.05 for
unilateral stimulation); and neither optical stimulation at
590nm nor stimulation outside of CN significantly
reduced the GSWD frequency power (p5 0.43 and
p5 0.81, respectively). Thus, the main findings from
CN treatment of absence seizures in tg could be repli-
cated in C3H/HeOuJ mutants.
Optogenetic Stimulation of Presumptively
Excitatory CN Neurons Affects GSWDs
To investigate the mechanism underlying the potent
interruption of GSWDs by optogenetic stimulation of
CN in tg and C3H/HeOuJ, we quantified the responses
of CN neurons to bilateral optical stimulation. In C3H/
HeOuJ and tg injected with AAV2-hSyn-ChR2(H134R)-
EYFP, 33 of 50 responsive cells (66%) showed increased
action potential firing, whereas 17 (34%) showed
decreased firing (see Fig 5A). A further 16 recorded neu-
rons showed no response to optical stimulation. This
variety of responses is in line with the properties of the
construct that was used to transfect CN neurons with
ChR2. Because human synapsin (hSyn) is not specific to
a certain type of neuron,50 both excitatory and inhibitory
CN neurons expressed ChR2. Excitatory responses can
FIGURE 3
FIGURE 3: Optogenetic stimulation of cerebellar nuclei reli-
ably stops generalized spike-and-wave discharges (GSWDs).
(A) Confocal image of sagittal brain section showing
channelrhodopsin-2 (ChR2) expression in cerebellar nuclei
(CN) with projections to the thalamus (M1, S1 represent pri-
mary motor and sensory cortex, respectively). (B) Represen-
tative electrocorticogram (ECoG) of bilateral M1 (left M1
[lM1], right [rM1], and left S1 [lS1] recording), which exem-
plifies how bilateral optogenetic stimulation (470nm light
pulse of 100 milliseconds indicated by the vertical blue bar)
stops GSWDs in all recorded cortices. (C) Mean ECoG wave-
let spectrogram of contralateral M1 for all bilateral (n525;
left panel) and unilateral stimuli (n511; right panel) pre-
sented to a single mouse at 470nm. (D) As in C for (left)
590nm stimuli (n536) and (right) stimulation at 470nm out-
side of CN (n518). (E; right) Typical example of the effect
of bilateral closed-loop stimulation on GSWD recorded in
contralateral M1 and S1 and (left) mean ECoG wavelet spec-
trogram of all unilateral stimuli (n544) presented to 1
mouse. (F) ECoG theta-band power before and after open-
loop (bilateral: 3 females, 1 male, n5178; unilateral: 3
female, n543) stimulations with the wrong wavelength
(590nm; 3 females, n5107) and stimulations outside the
CN (3 females; n5185) as well as the responses to closed-
loop stimulation at 470nm in the CN (bilateral: 3 females,
n5227; unilateral: 3 females, n549). ***p<0.001
(repeated measures analysis of covariance; see Table 5).
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be recorded from neurons that express ChR2, and inhibi-
tory responses can be recorded from neurons that do not
express ChR2 but that receive input from ChR2-positive
inhibitory neurons, but neurons devoid of ChR2 expres-
sion either in their membrane or synaptic afferents will
not show any response.
Next, we questioned to what extent the impact of
optogenetic stimulation of CN neuronal action potential
firing depends on the phase of the thalamocortical oscil-
lations, that is, to what extent the disruption of GSWD-
modulated CN firing was evoked during cortical excita-
tion (the ECoG spike) and/or cortical inhibition (the
ECoG wave).51 Because we did not design our stimula-
tion protocol to be activated with a fixed delay relative
to the GSWDs, we could answer this question by com-
paring the phase values of the onset of effective stimuli
relative to the spike-and-wave cycle in M1 and S1 corti-
ces with those of ineffective stimuli (see Fig 5). For both
M1 and S1, success rates were lowest when the stimulus
was applied up to 60 before the peak of a spike (ie,
300–360 in Fig 5C lower panels), but the overall dif-
ferences of these distributions did not reach statistical sig-
nificance (M1: p5 0.13; S1: p5 0.29). However,
effective stimuli evoked a significant shortening
(p< 0.01) of the interval between the last 2 ECoG
spikes, which is indicative of an excitatory effect on corti-
cal activity (Fig. 5D),51 and the timing of the last ECoG
spike could be predicted by the time of the stimulus
onset relative to the spike-and-wave cycle (p< 0.001; see
Fig 5E, Table 7). Together, our combined electrophysio-
logical and optogenetic data indicate that optogenetic
CN stimulation is most effective when applied during
the "wave" of the GSWD, during which cortical neurons
are normally silent.
Discussion
In this study, we show that in 2 unrelated mouse models
of absence epilepsy the activity of CN neurons can be
utilized to modulate the occurrence of GSWDs. We pro-
vide evidence that pharmacological interventions at the
level of CN can exert slow, but long-term, effects and
that optogenetic stimulation of CN neurons can exert
fast, short-term control. The different dynamics of these
experimental approaches, with converging outcomes,
align with the hypothesis that CN neurons can control
the balance of excitation and inhibition in the thalamus,
thereby resetting the oscillatory activity in thalamocorti-
cal loops. In both tg and C3H/HeOuJ strains of mice, a
substantial subset of CN neurons showed phase-locked
action potential firing during GSWDs, which is in line
with a previous study of oscillating cerebellar activity
during GSWDs in WAG/Rij and F344/BN rats.32 We
observed that 35% of neuronal recordings in the MCN
showed GSWD-modulated patterns, whereas the portions
TABLE 5. Effect of Optogenetic CN Stimulation on GSWD-Related Power
Tested Data Compared Groups N p F-value Statistical Test
Open-loop bilateral 470nm tg prestimulation 178 <0.001a F(1,176)5 74.87 Repeated measures ANCOVA
tg poststimulation
Open-loop unilateral 470nm tg prestimulation 43 <0.001a F(1,41)5 35.25 Repeated measures ANCOVA
tg poststimulation
590nm tg prestimulation 107 0.367 F(1,65)5 0.82 Repeated measures ANCOVA
tg poststimulation
470nm outside CN tg prestimulation 185 0.283 F(1,65)5 1.16 Repeated measures ANCOVA
tg poststimulation
Closed-loop bilateral
470nm
tg prestimulation 227 <0.001a F(1,65)5 456.3 Repeated measures ANCOVA
tg poststimulation
Closed-loop unilateral
470nm
tg prestimulation 49 <0.001a F(1,65)5 97.58 Repeated measures ANCOVA
tg poststimulation
Corresponds to Figure 3.
aStatistically significant.
ANCOVA5 analysis of covariance; CN5 cerebellar nuclei; GSWD5 generalized spike-and-wave discharge.
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of GSWD-modulated neurons in the IN and LCN were
higher (73% and 44%, respectively). Except for an ana-
tomical evaluation of the local density of large and small
soma-diameter CN neurons in the mouse brain52 and
computational studies on the clustering analysis of CN
neuronal action potential firing in tg,53,54 few experimen-
tal data are available that allow us to unequivocally pin-
point the type(s) of CN neurons responsible for
modification of GSWD activity. With respect to the
extracellular recordings, we presumably recorded mostly
FIGURE 4: Modulation of phase-locked cerebellar nuclei (CN) neuronal (CNN) activity stops generalized spike-and-wave dis-
charges (GSWDs) in C3H/HeOuJ mice. (A) Simultaneously recorded primary motor (M1) and sensory (S1) cortex electrocortico-
grams (ECoGs) and CNN activity. (B) Raster plot and peri–stimulus time histogram of single CNN activity (t50 indicates each
ECoG spike). AP5 action potential; SWD5 spike-and-wave discharge. (C) Summary bar plots representing the mean differences
in firing pattern parameters between interictal and ictal periods (n528). ***p<0.001 (repeated measures analysis of variance
[ANOVA] with Bonferroni corrections; see Table 6). (D) Representative M1 ECoG before and after muscimol injection and (E)
corresponding normalized seizure occurrence and duration. *p<0.05 (Friedman ANOVA; see Table 6). (F–H) Open-loop (top)
and closed-loop (bottom) optogenetic stimulation stops GSWDs as shown by: (F) typical example trace; (G) ECoG wavelet spec-
trogram averaged over all bilateral open-loop (n511; top panel) stimuli in a single mouse and over all unilateral closed-loop
stimuli (n518; bottom panel) in another mouse; and (H) ECoG theta-band power before and after optical stimulation for bilat-
eral open-loop stimuli (n53 mice, n519 stimulations; top left panel), unilateral open-loop stimuli (n53 mice, n519 stimula-
tions), bilateral closed- loop stimuli (n53 mice, n546 stimulations), and unilateral closed-loop stimuli (n53 mice, n530
stimulations). *p<0.05, **p<0.01 ***p<0.001 (repeated measures ANCOVA; see Table 6).
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TABLE 6. Neuronal Firing and Effect of CN Manipulations on GSWD Occurrence
Tested Data Compared Groups N p t or F-value Statistical Test
Differences in CN neuronal action potential firing
Coherence C3H/HeOuJ
GSWD-modulated
28 <0.001a t(66.6)5 5.92 Independent samples
t test
C3H/HeOuJ
non-modulated
51
Firing frequency C3H/HeOuJ
GSWD-modulated ictal
28 0.138 F(1,27)5 2.34 Repeated measures
ANOVA (Bonferroni)
C3H/HeOuJ
GSWD-modulated
interictal
Coefficient of variation C3H/HeOuJ
GSWD-modulated ictal
28 0.708 F(1,27)5 0.14 Repeated measures
ANOVA (Bonferroni)
C3H/HeOuJ
GSWD-modulated
interictal
CV2 C3H/HeOuJ
GSWD-modulated ictal
28 <0.001a F(1,27)5 21.35 Repeated measures
ANOVA (Bonferroni)
C3H/HeOuJ
GSWD-modulated
interictal
Burst index C3H/HeOuJ
GSWD-modulated ictal
28 <0.001a F(1,27)5 15.64 Repeated measures
ANOVA (Bonferroni)
C3H/HeOuJ
GSWD-modulated
interictal
Effects of pharmacological manipulations of CN neurons on GSWDs
GSWD occurrence C3H/HeOuJ premuscimol 4 <0.05a Friedman’s ANOVA
C3H/HeOuJ postmuscimol
GSWD duration C3H/HeOuJ premuscimol 4 0.317 Friedman’s ANOVA
C3H/HeOuJ postmuscimol
Effects of optogenetic CN stimulation on GSWD-related power
Open-loop bilateral 470nm C3H/HeOuJ
prestimulation
37 <0.01a F(1,35)5 8.17 Repeated measures
ANCOVA
C3H/HeOuJ
poststimulation
Open-loop unilateral 470nm C3H/HeOuJ
prestimulation
19 <0.001a F(1,17)5 20.32 Repeated measures
ANCOVA
C3H/HeOuJ
poststimulation
590nm in CN C3H/HeOuJ
prestimulation
47 0.809 F(1,45)5 0.06 Repeated measures
ANCOVA
C3H/HeOuJ
poststimulation
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from CN neurons with a large soma-diameter,55 which
incorporates mainly excitatory glutamatergic neurons,56
but in the MCN also inhibitory glycinergic projection
neurons.57 Interestingly, GSWD-modulated CN neurons
also showed characteristic firing patterns during the peri-
ods in between seizures. During these interictal periods,
they fired at higher frequencies with a more irregular and
burstlike pattern than the CN neurons that did not
comodulate with GSWDs. Thus, the interictal firing pat-
tern of CN neurons in tg and C3H/HeOuJ mice appears
to reliably predict whether these cells will show oscilla-
tions phase-locked to GSWDs during seizures.
Pharmacological manipulation of neuronal activity
in the cerebellum proved effective when the injections of
muscimol or gabazine were aimed at the CN, but not
when the cerebellar cortex was targeted.
We found that gabazine application was effective in
reducing GSWD occurrence in all CN, with the most
pronounced effects in IN and LCN. Along the same line,
muscimol injections in IN and LCN evoked the biggest
increase in GSWD occurrence. Effects of MCN injec-
tions were smaller but still significant. Because we know
little about the density of individual types of neurons
throughout the murine MCN, IN, and LCN,52,56 and
considering the similarity in effects of gabazine and mus-
cimol on neuronal activity in these nuclei, we cannot
draw a firm conclusion about a potentially differential
effect of either gabazine or muscimol on the respective
nuclei. These data raise the possibility that the difference
in impact on GSWD occurrence between manipulation
of MCN versus that of IN and LCN does not reflect a
difference in intrinsic activity, but rather a difference in
their efferent projections to the brainstem, midbrain, and
thalamus.24 Although all CN have been shown to project
to a wide range of thalamic subnuclei, such as the ven-
trolateral, ventromedian, centrolateral, centromedian, and
parafascicular nuclei,24,58 and thereby connect to a vari-
ety of thalamocortical networks, the impact of IN and
LCN has been shown to focus on the primary motor
cortex, whereas MCN impact more diffusely on thalamo-
cortical networks.59
CN axons that project to the thalamus have been
shown to originate from glutamatergic neurons, which
synapse predominantly perisomatically and evoke sub-
stantial excitatory responses.4,6,23–29 Upon CN injections
with muscimol, we must in effect have substantially
reduced the level of excitation of thalamic neurons and
thereby disturbed the balance of inhibition and excitation
in thalamocortical networks in favor of inhibition. One
of the main consequences of hyperpolarizing the mem-
brane potential of thalamic neurons through this inhibi-
tion is activation of hyperpolarization-activated
depolarizing cation currents (Ih) and CaV3.1 (T-type)
Ca21 channel currents, which typically results in the
burstlike action potential firing that can drive GSWDs in
thalamocortical networks.7,8,60,61 Moreover, in tg tha-
lamic relay neurons show increased T-type Ca21 channel
currents,62 which probably act synergistically with the
decreased excitation following muscimol treatment, likely
further increasing GSWD occurrence. In contrast, when
TABLE 6: Continued
Tested Data Compared Groups N p t or F-value Statistical Test
470nm outside CN C3H/HeOuJ
prestimulation
56 0.425 F(1,54)5 0.65 Repeated measures
ANCOVA
C3H/HeOuJ
poststimulation
Closed-loop bilateral 470nm C3H/HeOuJ
prestimulation
46 <0.001a F(1,44)5 14.20 Repeated measures
ANCOVA
C3H/HeOuJ
poststimulation
Closed-loop unilateral 470nm C3H/HeOuJ
prestimulation
30 <0.05a F(1,28)5 4.60 Repeated measures
ANCOVA
C3H/HeOuJ
poststimulation
Corresponds to Figure 4.
aStatistically significant.
ANCOVA5 analysis of covariance; ANOVA5 analysis of variance; CN5 cerebellar nuclei; GSWD5 generalized spike-and-wave
discharge.
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we applied gabazine to CN, the balance of inhibition
and excitation in the thalamocortical networks probably
shifted toward excitation and thereby may have prevented
the activation of Ih and T-type Ca
21 channel currents,
reducing the occurrence of burst firing and GSWDs.
The successful application of short periods of optogenetic
excitation of CN neurons not only confirmed the
deoscillating impact of gabazine, but further refined it by
revealing that GSWDs can be most efficiently stopped
when the interval between ECoG spikes, that is, wave-
length of the oscillations, is instantly shortened and
thereby reset. Given the relatively low success rate of
optogenetic stimulation in the period just preceding the
"spike" state of the GSWDs, which reflects the excitation
state of the thalamocortical relay neurons, it is parsimo-
nious to explain the effective resetting through optimal
interference during the inhibitory or "wave" state of the
GSWD.51 This explanation centered on the resetting
hypothesis argues against the possibility that GSWDs
were terminated by optogenetic activation of the CN
neurons that were inhibited. Regardless of the net effect
of CN stimulation on thalamocortical networks, the cur-
rent approach proved equally effective when applied
bilateral or unilateral. Most likely, instantly resetting the
balance of excitation and inhibition in thalamocortical
relay neurons on one side of the brain will also engage
the other side through combined ipsi- and contralateral
projections from the CN to the thalamus and through
interthalamic and intercortical connections.6,24,63
It remains to be established to what extent the cur-
rent findings for absence epilepsy can help to treat epi-
leptic patients suffering from other types of seizures. Our
findings on the impact of optogenetic manipulation of
CN firing patterns on GSWD occurrence seem to sup-
port the (pre)-clinical studies that apply deep brain stim-
ulation (DBS)64,65 in the CN may be an option to treat
epilepsy patients. So far, only 3 clinical studies applying
electrical DBS to the CN have been reported, which is
in contrast to the dozens of studies performed to investi-
gate the therapeutic use of cerebellar surface stimulation
(as reviewed by Krauss and Koubeissi66). Although
FIGURE 5
FIGURE 5: Excitatory impact of optical cerebellar nuclei (CN)
stimulation on cortical activity stops generalized spike-and-
wave discharge (GSWD) episodes. (A; left panels) Peri–stimu-
lus time histogram and raster plot indicating increased (top)
or decreased (bottom) action potential (AP) firing for individ-
ual CN neurons evoked by 470nm light pulses (blue bars).
Right panels: Scatterplots represent the individual changes in
CN neuronal firing following optical stimulation: (left)
increased firing (n533); (right) decreased firing (n517).
Black and blue bars indicate mean firing frequency when the
470nm light-emitting diode was turned off or on, respec-
tively. (B) Examples of stopped (left) and continuing (right)
GSWD episodes upon optogenetic stimulation. Black hori-
zontal arrows represent the median time interval between
electrocorticogram (ECoG) spikes, which correspond to 1
cycle of cortical oscillation, here represented as 360. Green
and red vertical arrows represent the onset of the light stim-
ulus. (C) Rose plots of the start of successful and unsuccess-
ful optical stimulation in the 360 GSWD cycle for both
primary motor cortex (left) and primary sensory cortex
(right). (D) Comparison between the median and the last
interval (between the last 2 ECoG spikes) for stopped and
continuing GSWD episodes. ***p<0.001 (repeated measures
ANCOVA; see Table 7). (E) Scatterplot representing the pre-
dictability of the stimulus-related time interval between
GSWDs by the phase of stimulation onset. p<0.001 (linear
regression analysis; see Table 7).
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initially promising, the clinical studies on the effects of
cerebellar surface stimulation reported inconsistent
results,12–21 which may partially be due to suboptimal
placement of electrodes. Unlike the current results, which
show a regional preference for the effect of lateral CN
stimulation on GSWD occurrence, it was recently shown
that manipulating Purkinje cells in the medial cerebellum
is most effective in controlling kainate-induced temporal
lobe epilepsy.67 So far, the studies that applied DBS at
the level of CN in an uncontrolled fashion report highly
effective decreases in the level of seizures (corresponding
to class IC and IIIA of the Engel scale68) in a low num-
ber of patients characterized with various types of epi-
lepsy.69–71 Apart from the coherence in location of
stimulation (laterally located nucleus dentatus), these
studies used a wide variety in CN stimulus regimes,
ranging from 3 minutes per day to continuous electrical
stimulation for 12 to 14 hours per day. It appears that
high-frequency stimulation (>50Hz), but not low-
frequency stimulation (1–40Hz), is most effective when
applied to the cerebellar dentate nucleus. In the present
study, we found that the increase in CN neuronal action
potential firing frequency upon optogenetic stimulation
was highly variable (see Fig 4), and thus our current
results do not provide any ground for a conclusion on
whether low- or high-frequency stimulation would be
advantageous to stop GSWD episodes. However, our
results do provide sufficient data to conclude that the
temporal precision determines the level of efficiency, for
example, by stimulating with short pulses as soon as an
epileptic event starts to occur and if possible in a proper
temporal relation with respect to the inhibitory wave of
the GSWDs.
Because absence epilepsy is a commonly prevalent
but in essence a benign form of generalized epilepsy,1
DBS will not very likely be considered as a serious
option. However, patients diagnosed with other forms
of epilepsy who do not benefit sufficiently from medi-
cation may be eligible for (cerebellar) DBS.47 Currently,
the options for applying DBS are limited; only the
anterior thalamic nucleus is currently described in the
US Food and Drug Administration guidelines to treat
intractable epilepsy, and although promising, the out-
come is limited and can result in cognitive and emo-
tional problems.72,73 Given the powerful impact of CN
stimulation on thalamocortical activity that is shown in
the present study, we hypothesize that CN stimulation
may also exert very positive effects in these other, more
severe kinds of epilepsies.
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